Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
Final Program - American Society of Gene & Cell Therapy
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Exhibitor Descriptions<br />
National <strong>Gene</strong> Vector Biorepository (NGVB)<br />
980 W. Walnut Street R3 C602<br />
Indianapolis, IN 46202<br />
Phone: (317) 274-4519<br />
Fax: (317) 278-3327<br />
E-mail: lrubin@iupui.edu<br />
Website: https://www.ngvbcc.org<br />
Booth Number: 412<br />
The National <strong>Gene</strong> Vector Biorepository provides support<br />
for gene therapy research by <strong>of</strong>fering several services. Check<br />
out the reagent repository comprising cell lines, plasmids,<br />
vectors and other tools used in gene therapy research. There<br />
are archiving services to meet FDA requirements. The NGVB<br />
will store clinical post-trial samples, inal product reserves,<br />
and master cell banks as well as pharmacology/toxicology<br />
samples. A pharm/tox database containing gene therapy<br />
tox studies is a valuable resource. We <strong>of</strong>fer assistance<br />
with insertional mutagenesis analysis through the SeqMap<br />
Bioinformatics Tool. Check out the <strong>Gene</strong> <strong>Therapy</strong> Data Map a<br />
tool for locating gene therapy research. Go to https://www.<br />
ngvbcc.org or come and see us in Booth 412.<br />
Nature Publishing Group<br />
75 Varick Street, 9th Floor<br />
New York, NY 10013-1917<br />
Phone: (212) 726-9200<br />
Fax: (212) 689-9711<br />
E-mail: institutions@nature.com<br />
Website: www.nature.com<br />
Booth Number: 402<br />
Nature Publishing Group brings you leading scientiic and<br />
medical research. The NPG portfolio combines the continued<br />
excellence <strong>of</strong> Nature, its associated research and review<br />
journals, and 50 leading academic and society journals in the<br />
life, physical and clinical sciences. Visit Booth 402 for free<br />
sample copies.<br />
Nature Technology Corporation<br />
4701 Innovation Drive<br />
Lincoln, NE 68521<br />
Phone: (402) 323-6289<br />
Fax: (402) 323-6292<br />
E-mail: hodgson@natx.com<br />
Website: www.natx.com<br />
Booth Number: 312<br />
Nature Technology Corporation is a biotechnology<br />
company that provides industry partners with world class<br />
technology platforms including safe and eficacious nonviral<br />
vectors (plasmids) and processes for gene therapy<br />
and DNA vaccination vector production. NTC also provides<br />
cost effective outsourcing <strong>of</strong> product development services<br />
including synthetic gene design, vector construction, plasmid<br />
DNA manufacturing and recombinant proteins.<br />
Nexcelom Bioscience<br />
360 Merrimack Street, Building 9<br />
Lawrence, MA 01843<br />
Phone: (978) 327-5340<br />
Fax: (978) 327-5341<br />
E-mail: lvavra@nexcelom.com<br />
Website: www.nexcelom.com<br />
Booth Number: 114<br />
Nexcelom’s <strong>Cell</strong>ometer line <strong>of</strong> simple-to-use cell counters<br />
automate manual cell counting procedures by obtaining<br />
accurate counts, viability, and cell sizes in less than 30<br />
seconds & only 20uL <strong>of</strong> sample. Fluorescence detection<br />
capabilities enable fast & simple determination <strong>of</strong> GFP<br />
transfection rates, PI-viability, & direct counting <strong>of</strong> WBCs<br />
without lysing.<br />
NHLBI <strong>Gene</strong> <strong>Therapy</strong> Resource <strong>Program</strong><br />
2 Rockledge Center, 6701 Rockledge Drive<br />
Bethesda, MD 20892-7940<br />
Phone: (301) 435-0477<br />
Fax: (301) 628-1929<br />
E-mail: gtrpccc@s-3.com<br />
Website: www.gtrp.org<br />
Booth Number: 408<br />
The NHLBI <strong>Gene</strong> <strong>Therapy</strong> Resource <strong>Program</strong> (GTRP)<br />
facilitates the translation <strong>of</strong> gene therapy research<br />
into clinical interventions primarily in heart, lung, and<br />
blood diseases. Services provided by the <strong>Program</strong><br />
include preclinical and clinical-grade vector production,<br />
pharmacology/toxicology testing, immunology testing,<br />
assistance with regulatory activities, and partial inancial<br />
support <strong>of</strong> clinical trials.<br />
NIH Office <strong>of</strong> Biotechnology Activities<br />
6705 Rockledge Dr.<br />
Suite 750<br />
Bethesda, MD 20892-7985<br />
Phone: (301) 496-9838<br />
Fax: (301) 496-9839<br />
E-mail: oba@od.nih.gov<br />
Website: http://oba.od.nih.gov<br />
Booth Number: 105<br />
NIH Ofice <strong>of</strong> Biotechnology Activities staff is available to<br />
answer questions about human gene transfer research<br />
under the NIH Guidelines and provide information about<br />
GeMCRIS, a web-based, information resource and analytical<br />
tool that provides information about HGT trials and enables<br />
investigators to ile adverse event and annual reports<br />
electronically.<br />
82<br />
<strong>Final</strong> <strong>Program</strong> SALT LAKE CITY, UTAH May 15–18, 2013